Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05808712
Other study ID # ACS
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2023
Est. completion date December 31, 2028

Study information

Verified date April 2023
Source Linkoeping University
Contact Jenny Drott, PhD
Phone +46 732701839
Email Jenny.Drott@liu.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Surgery is often a central curative treatment for gastrointestinal tumors. Surgical treatment of diagnosed cancer tumors is decided after a comprehensive assessment of the patient's physical status, radiological assessments and after careful evaluation at the multidisciplinary conference. Despite the careful preoperative assessment of patients for curative surgery, the planned operation may unexpectedly need to be canceled. Of the patients who were planned for curative resection for pancreatic cancer in 2021 in Sweden, 90% received the intended surgery, and 10% of planned surgery was canceled. The reason for this was disseminated cancer or locally advanced disease in which radical resection is considered impossible to carry out. A systematic review of knowledge reveals a significant lack of evidence regarding patient-centered research and aborted cancer surgery. The studies in the project have different study designs and methods, and include focus group interviews with staff, translation and validation of a questionnaire to measure care needs, estimation of supportive care needs and patient experiences. An improved understanding and knowledge of patients' preferences and needs is needed to design interventions that can improve health-related quality of life. This project is dedicated to studying patients undergoing aborted cancer surgery, with the aim of improving the quality of care and meeting patients' care needs.


Description:

The overall objective of this research project is to: - describe the patients experiences and assess supportive care needs following aborted cancer gastrointestinal surgery - increase knowledge of the healthcare professionals' experiences of aborted cancer surgery from a multi-professional and continuum of cancer care perspective - increase our clinical knowledge of patient preferences and healthcare professionals' perspective to develop tailored patient-centered interventions with the goal to improve quality of cancer care


Recruitment information / eligibility

Status Recruiting
Enrollment 350
Est. completion date December 31, 2028
Est. primary completion date December 31, 2028
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - >18 years - cancer patients with different gastrointestinal cancer diagnosis Exclusion Criteria: - not able to answer the questionnarie SCNS-SF34 in Swedish.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
validation
Translation and validation design

Locations

Country Name City State
Sweden Department of Surgery Linköping
Sweden Jenny Drott Linköping

Sponsors (1)

Lead Sponsor Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary supportive care needs, questonnarie psychometric properties in the swedish version of the questionnarie SCNS-SF34 March 2023 - March 2024
Primary Rate of supportive care needs in cancer assessment of supportive care needs via the questionnarie SCNS-SF34 (in Swedish) March 2023 - March 2024
See also
  Status Clinical Trial Phase
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Withdrawn NCT03538613 - Study of People With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System Phase 1/Phase 2
Recruiting NCT04426669 - A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering Phase 1/Phase 2
Recruiting NCT04859400 - Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients N/A
Recruiting NCT05406167 - Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System